Skip Navigation


NDT Advance Access originally published online on January 5, 2007
Nephrology Dialysis Transplantation 2007 22(3):681-683; doi:10.1093/ndt/gfl735
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/3/681    most recent
gfl735v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in NDT
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Friedman, E. A.
Right arrow Articles by Friedman, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, E. A.
Right arrow Articles by Friedman, A. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Is there really good news about pandemic diabetic nephropathy?*,{dagger}

Eli A. Friedman1 and Amy L. Friedman2

1Department of Medicine, Downstate Medical Center, Brooklyn, NY and 2Department of Surgery, Yale University, School of Medicine, New Haven, CT, USA

Correspondence and offprint requests to: Eli A. Friedman, MD, Department of Medicine, Downstate Medical Center, 450 Clarkson Avenue Brooklyn, New York 11203, USA. Email: elifriedmn@aol.com

Keywords: diabetes; diabetic nephropathy; end stage renal failure (ESRD); epidemiology; pandemic; renoprotection; uraemia; USRDS

The first 10% of the full text of this article appears below.

Defined in the dictionary as an adjective, the word pandemic, meaning: ‘occurring over a wide geographic area and affecting an exceptionally high proportion of the population,’ like epidemic, has evolved to its current usage as a noun [1]. In 2005, growth in number of individuals in the United States treated for end-stage renal disease (ESRD) was analysed using data generated by the United States Renal Data system (USRDS), sustaining the conclusion that most of the expansion ‘was due to a three-fold increase in risk of ESRD in people with diabetes and therefore, qualifies as an epidemic (Figure 1) [2].’ Examination of the epidemic growth curve of diabetes [3] pointed to diabetes mellitus as the leading cause of ESRD (i.e. kidney failure requiring dialysis or transplantation) in the United States, accounting for 44% of new cases of treated ESRD in . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in NDT:

Has the rise in the incidence of renal replacement therapy in developed countries come to an end?
Kitty J. Jager and Paul C. W. van Dijk
NDT 2007 22: 678-680. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
A. Covic, P. Gusbeth-Tatomir, and D. Goldsmith
Negative outcome studies in end-stage renal disease: how dark are the storm clouds?
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 56 - 61.
[Full Text] [PDF]